Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original articles, letters and communications in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology. Commentaries and Point-Counterpoint provide a forum for perspectives in clinical pharmacology and therapeutics in the context of contemporary scientific, political, economic and social issues. State of the Art contributions summarize the latest advances in the science underpinning drug discovery, development, regulation and utilization. CPT highlights issues transforming the practice of clinical pharmacology, including ethics, education and public policy. Bench-to-bedside translation in therapeutics is presented in the context of clinical applications of basic pharmacology, discovery and translational medicine, and drug development.

臨床藥理學(xué)與治療學(xué)(CPT)是實(shí)驗(yàn)醫(yī)學(xué)和臨床醫(yī)學(xué)的權(quán)威交叉學(xué)科期刊，致力于發(fā)表治療學(xué)的性質(zhì)、作用、療效和評價方面的進(jìn)展。CPT歡迎翻譯、預(yù)測和個性化醫(yī)學(xué)新興領(lǐng)域的原創(chuàng)文章、信函和通信;新的治療方式包括基因和細(xì)胞療法;藥物基因組學(xué)、蛋白質(zhì)組學(xué)和代謝組學(xué);生物信息和應(yīng)用系統(tǒng)生物學(xué)補(bǔ)充藥物動力學(xué)和藥效學(xué)、人體調(diào)查和臨床試驗(yàn)、藥物警戒、藥物流行病學(xué)、藥物計(jì)量學(xué)和人口藥理學(xué)等領(lǐng)域。評論和觀點(diǎn)對位提供了一個論壇的觀點(diǎn)，臨床藥理學(xué)和治療在當(dāng)代科學(xué)，政治，經(jīng)濟(jì)和社會問題的背景下。《最新進(jìn)展》綜述了支持藥物發(fā)現(xiàn)、開發(fā)、管理和利用的科學(xué)方面的最新進(jìn)展。CPT強(qiáng)調(diào)轉(zhuǎn)變臨床藥理學(xué)實(shí)踐的問題，包括倫理、教育和公共政策。在臨床應(yīng)用的基礎(chǔ)藥理學(xué)，發(fā)現(xiàn)和翻譯醫(yī)學(xué)，以及藥物開發(fā)的背景下，治療的基準(zhǔn)到床邊翻譯。